Atlas Trials

Metastatic Nasopharyngeal Carcinoma

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic Nasopharyngeal Carcinoma

RecordFirmDate
Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study (NCT04872582)XIANG YANQUN2021-07-29
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer (NCT04458909)National Cancer Institute (NCI)2020-12-09
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864)Alain Algazi2020-12-01
A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04627961)National University Hospital, Singapore2020-08-26
Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma. (NCT04405622)Sun Yat-sen University2020-05-30
Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure (NCT04586088)Sun Yat-sen University2020-05-05
Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma (NCT03639467)Chinese Academy of Medical Sciences2018-09-18
Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT01392235)Jiangsu HengRui Medicine Co., Ltd.2011-07-01

Track Metastatic Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.